Japan essential medicine list and medicine supply issues: a cross-sectional study
Camila Heredia, Hayase Hakariya, Akihiko Ozaki, Navindra Persaud · 2026
Read Japan essential medicine list and medicine supply issues: a cross-sectional study by Camila Heredia, Hayase Hakariya, Akihiko Ozaki, Navindra Persaud (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13220582.txt.
Description
Camila Heredia and co-authors cross-check Japan's essential medicines list against the country's medicine supply problems in a 2026 study. Essential medicines lists are meant to guarantee the drugs a population most needs, and Japan pairs universal coverage with promotion of cheap generics, a policy now blamed for shortages. Whether listing protects a medicine from supply trouble was the open question.
The analysis worked from the April 2024 pharmaceutical supply survey, deduplicated to 1,107 unique medicines by ingredient and route. Of these, 401, thirty-six percent, had shipping or supply issues, generating 847 problem entries. Being on the 2024 essential list was no shield: eighty of its 167 medicines, half, had supply issues. Causes ranged from pricing decisions and quality failures to manufacturing trouble, demand spikes, and raw material shortages, with antibiotics the hardest-hit group. The authors call for continuous list updates and a national supply strategy so priority status means availability.
Catalog record
| CREATOR | Camila Heredia, Hayase Hakariya, Akihiko Ozaki, Navindra Persaud |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |